Cathay Capital
Cathay Capital Private Equity invests from growth-stage opportunities through buyouts, with majority or minority investments and active board participation.
Cathay Capital Private Equity targets small to midsize companies across North America, Europe, and Asia.
Its stated model includes growth investments through buyouts, majority or minority positions, sole-investor or consortium transactions, and support involving digital transformation, talent acquisition, add-on acquisitions, joint ventures, manufacturing-capacity optimization, and international expansion.[1][2][5][6]
What does Cathay Capital invest in?
Cathay Capital describes itself as a global investment platform whose group includes Cathay Capital Private Equity, Cathay Innovation, and Cathay Health. Cathay Capital Private Equity invests in small to midsize companies and supports management teams addressing globalization and sustainable digital transformation.[1][2]
Cathay Capital Private Equity states that it invests across growth-stage opportunities through buyouts in North America, Europe, and Asia. It can invest as a majority or minority investor, either as a sole investor or as part of a consortium, and describes itself as a long-term partner with active board participation.
The private-equity strategy also identifies support areas including digital transformation, talent acquisition, add-on acquisitions and joint ventures, and manufacturing-capacity optimization.[2]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Cathay Capital?
An owner evaluating Cathay should clarify which Cathay legal entity and fund would invest, whether the proposed transaction would be a majority buyout, minority growth investment, or consortium transaction, and what governance rights would apply. The owner should also ask about the relevant fund’s target revenue, EBITDA, enterprise-value, or equity-check parameters, management rollover, contemplated leverage, any add-on or international expansion plan, expected investment horizon and exit approach, and references for comparable transactions.
Cathay’s stated model includes active board participation, digital transformation, talent acquisition, add-on acquisitions, joint ventures, and international expansion. These points should be addressed directly in discussions about the proposed transaction rather than treated as established terms for a particular deal.[2]
Is the proposed transaction intended to be a majority buyout, minority growth investment, or consortium transaction
What target revenue, EBITDA, enterprise-value, or equity-check parameters apply to the relevant fund
What companies does Cathay Capital target?
Cathay describes its private-equity target as small to midsize companies. Its Small Cap Growth PE strategy has a latest fund size of 250-300 M€ and covers growth-stage investments through buyouts. The strategy permits majority or minority positions.
The sources cited for this profile do not establish specific revenue, EBITDA, enterprise-value, or equity-check thresholds.[2]
Cathay’s private-equity materials identify healthcare, consumer goods, services and education, business transformation and software, and financial industries among its sectors. Its portfolio taxonomy also includes B2B software and services, consumer products and services, energy, mobility and industry, and financial industries and fintech.[2][3]
Cathay states that its private-equity activity covers North America, Europe, and Asia. Its official contact page lists locations in San Francisco, Paris, Shanghai, Munich, Beijing, New York, and Singapore.[2][4]
Cathay presents a model that combines equity capital with local-market networks, sector knowledge, digital-transformation support, management recruitment, add-on acquisitions, joint ventures, and international expansion. Recent public announcements include platform-building and add-on activity, but the sources cited for this profile do not establish a uniform transaction structure for every investment.[2][6][7][8][9]
Cathay’s official portfolio page identifies Datawords, Moose Knuckles, Chime, Tissium, Juliette Has a Gun, and PDD among featured investment examples.[3]
On June 16, 2026, Cathay Capital acquired a majority stake in Equadis, with existing shareholders and management reinvesting alongside Cathay Capital.
On June 30, 2026, Cathay announced the launch of Ascendia Autism Care. The platform began with a founding affiliate operating 20 centers across eight states; the announcement states that financial terms were not disclosed.
On April 24, 2026, Parkview Dental Partners, a Cathay Capital-backed dental service organization, announced its acquisition of VIP Dental, bringing the platform to 25 practices. On September 1, 2026, Powell announced its acquisition of Synigo; the transaction closed on August 6, 2026, and Powell is backed by Cathay Capital, which became its majority shareholder in October 2025.
Cathay also announced the August 17, 2026 launch of ReDream Brands, a sleep-health platform formed following strategic transactions by Cathay-backed cpap.com, including a joint venture with AdaptHealth and the acquisition of Lofta.[5][6][7][8][9]
What is not clear from Cathay Capital's public investment criteria?
The sources cited for this profile do not establish a numeric investment holding-period range or standard exit timetable; the official private-equity strategy page describes Cathay as a long-term partner.
The official Equadis announcement does not disclose the purchase price, enterprise value, financing terms, or consideration details for the majority investment. The official Ascendia announcement states that financial terms were not disclosed.[2][5][6]
Questions to ask when evaluating Cathay Capital as a buyer or investment partner
Which Cathay legal entity and fund would invest in the proposed transaction?
Is the proposed transaction intended to be a majority buyout, minority growth investment, or consortium transaction?
What target revenue, EBITDA, enterprise-value, or equity-check parameters apply to the relevant fund?
What board rights and management rollover would be expected?
How much leverage is contemplated?
What add-on or international expansion plan would apply?
What is the expected investment horizon and exit approach?
Which portfolio-company references are available for comparable transactions?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Industry / market focus
- Geography / market coverage
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.